Camp4 Therapeutics reported cash from operations of -$12.70M and free cash flow of -$13.00M for the quarter ended Jun 2026, down 22.8% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -11.70M | -12.99M | -12.48M | -12.43M | -13.48M | -13.28M | -12.51M | -12.57M | -13.23M | -12.07M | -12.16M | -12.57M |
| Share-based Compensation | 0.72M | 0.64M | 0.86M | 0.79M | 2.08M | 0.80M | 0.86M | 1.00M | 0.98M | 1.15M | 1.47M | 1.93M |
| Asset Writedowns and Impairment | 0.49M | -0.01M | ||||||||||
| Cash from Operations | -11.78M | -11.14M | -13.44M | -9.69M | -11.29M | -14.29M | -10.34M | -11.22M | 6.25M | -11.00M | -12.70M | |
| Depreciation, Depletion & Amortization | ||||||||||||
| Amortizatization of Intangibles | 0.40M | 0.43M | 0.45M | 0.46M | 0.47M | 0.48M | 0.49M | 0.48M | 0.03M | 0.06M | ||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.43M | 0.44M | 0.42M | 0.42M | 0.42M | 0.42M | 0.43M | 0.42M | 0.37M | 0.52M | 0.52M | |
| Change in Working Capital | ||||||||||||
| Change in Account Payables | -0.15M | 0.98M | -1.04M | 1.08M | -0.86M | 0.17M | -0.19M | -0.55M | -0.47M | 0.59M | 0.32M | |
| Change in Accured Expenses | 0.56M | 0.45M | -1.48M | 0.72M | 1.84M | -2.79M | 1.03M | 1.36M | 1.20M | -1.37M | -0.45M | |
| Other Working Capital Changes | 0.09M | 1.20M | -0.65M | -0.20M | 0.37M | 0.01M | -1.46M | 1.56M | 0.78M | -0.97M | 0.64M | |
| Investing Activities | ||||||||||||
| Capital Expenditures | 0.24M | 0.15M | 0.03M | 0.26M | 0.28M | 0.10M | 0.30M | |||||
| Cash from Investing Activities | -0.24M | -0.01M | -0.16M | -0.26M | -0.28M | 0.04M | -0.13M | |||||
| Financing Activities | ||||||||||||
| Other financing activities | -0.03M | -17.63M | ||||||||||
| Change in Capital Stock | ||||||||||||
| Net Equity Issued and Repurchased | -0.01M | 0.00M | 0.03M | 76.32M | ||||||||
| Misc. | ||||||||||||
| Cash from Financing Activities | -0.06M | -0.20M | -0.81M | -0.39M | 73.06M | -0.15M | 0.07M | 47.38M | 28.59M | 0.06M | 0.00M | |
| Change in Cash | -12.09M | -11.36M | -14.41M | -10.08M | 61.51M | -14.72M | -10.27M | 36.20M | 34.88M | -10.92M | -12.81M | |
| Free Cash Flow | -12.03M | -11.29M | -13.46M | -9.69M | -11.55M | -14.56M | -10.34M | -11.22M | 6.25M | -11.10M | -13.00M | |
| Net Cash Flow | -12.09M | -11.36M | -14.41M | -10.08M | 61.51M | -14.72M | -10.27M | 36.20M | 34.83M | -10.94M | -12.82M |